Skip to main content

Cathie Wood Watch: Ark Seeks to 3D-Print Investing Profits

Wood's Ark Investment Management continues its buying and selling of stocks -- mostly buying.
  • Author:
  • Publish date:

Investment star Cathie Wood, Chief Executive of Ark Investment Management, continues her buying and selling of stocks -- mostly buying -- amid the equity market’s turmoil.

On Friday, she ventured into 3D printer companies, snagging Stratasys  (SSYS)  and Velo3D  (VLD) . Ark also continued its foray into biotechnology stocks, purchasing Adaptive Biotechnologies  (ADPT) , Burning Rock Biotech  (BNR)  and Atai Life Sciences  (ATAI) .

Among big-name companies, Ark snared e-commerce stalwart Shopify  (SHOP)  and sold e-signature company DocuSign  (DOCU) .

Ark Autonomous Technology & Robotics ETF  (ARKQ)  bought 50,299 shares of Stratasys, valued at $1.2 million as of Friday’s close. Ark funds purchased 21,944 shares of Velo3D, valued at $153,608 at Friday’s close.

Ark Genomic Revolution ETF  (ARKG)  bought 367,391 shares of Adaptive Biotech, valued at $4 million as of Friday’s close. Ark Genomic purchased 62,031 shares of Burning Rock Biotech, valued at $460,270 as of Friday’s close. Ark Genomic bought 61,840 shares of Atai, valued at $322,805 at Friday’s close.

As for the big names, Ark Fintech Innovation ETF  (ARKF)  purchased 12,864 shares of Shopify, valued at $7 million as of Friday’s close. And Ark Fintech sold 158,595 shares of DocuSign, valued at $11.6 million at Friday’s close.

Ark discussed DocuSign in a commentary Friday. Shares of DocuSign traded down 20% that day, Ark noted. The drop came after the company’s fourth-quarter earnings report, “in which management guided to further revenue deceleration and announced leadership changes across its ‘go-to-market’ organization,” Ark said.